C:Solid lipid nanoparticles: a prospective approach for topical drug delivery. | ||||
| Records of Pharmaceutical and Biomedical Sciences | ||||
| Article 13, Volume 4, Issue 2, July 2020, Page 8-16 PDF (521.58 K) | ||||
| Document Type: Mini-reviews | ||||
| DOI: 10.21608/rpbs.2019.18556.1045 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
passant mohamed Al-maghrabi   1; Shadeed Gad 2; Elsayed Khafagy3; Mamdouh Ghorab2
| ||||
| 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt | ||||
| 2Faculty of Pharmacy - Suez Canal University | ||||
| 3Dept. of Pharmaceutics Faculty of Pharmacy, Suez Canal University | ||||
| Abstract | ||||
| Solid lipid nanoparticles (SLNs) are categorized as a novel generation of nanocarriers attracting huge attention as innovative colloidal carrier systems used for drug delivery as they integrate the advantages and avoid the disadvantages of other colloidal carries such as liposomes as well as polymeric nanoparticles. SLNs are biocompatible and biodegradable carrier system made from physiological lipids, which decrease the danger of cute and chronic toxicity. Moreover, SLNs have been used as a possible attractive drug-carrier for topical drug delivery. Drug delivery to the skin is widely used for local and systemic delivery and has potentials to be improved by application of nanoparticulate formulations. This review discus on many aspects of SLNs such as their advantages and disadvantages, method of preparation, excipients influence, SLNs and topical delivery and their therapeutic applications. SLNs are promising delivery carriers for lipophilic as well as hydrophilic drugs and can form a base in the field of modern pharmaceutics. | ||||
| Keywords | ||||
| Keywords: Solid lipid nanoparticles; Colloidal carriers; Topical delivery; nanotechnology | ||||
|
Statistics Article View: 458 PDF Download: 534 |
||||
